Enzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate Cancer
Clinical trial NCT02012296 · COMPLETED
Trial details
- NCT number
- NCT02012296
- Sponsor
- University of Chicago
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-13
- Primary completion
- 2019-06-10
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.